Friday, July 28, 2006

BMS - Plavix: "an erosion of already fragile credibilty"

Back story.

Now J.P. Morgan has cut BMS to neutral from overweight, citing the uncertainties involving the form, implications and timing impact of the newly disclosed Department of Justice criminal investigation.

Significantly they noted BMS were management slow to disclose the issues and said it fears "an erosion of already fragile credibility."

marketwatch.com

No comments: